Table 1. Ultrasensitive viral load measurements.
Macaque | Time (in days) | Viral RNA (copies/mL) | Spike copies original count (RNA copies/mL) |
P157 | 204 and 239 (see Fig. 2) | <3 | * 7008 |
P185 | 204 and 239 (see Fig. 2) | <3 | * 10822 |
P188 | 204 and 239 (see Fig. 2) | <3 | * 8194 |
P177 | 312 and 347 (see Fig. 8) | <3 | * 7692 |
§591 and 599 (see Fig. 8) | <3 | ** 6062 | |
§654 and 658 (see Fig. 8) | <3 | ** 9060 | |
P252 | §215 and 365 (see Fig. 8) | <3 | ** 6201 |
4416 | 238 and 272 (see Fig. 4) | <3 | * 8276 |
BD12 | 98 and 105 (see Fig. 4) | <3 | ** 9319 |
BD53 | 98 and 105 (see Fig. 4) | <3 | ** 8494 |
BD64 | 400 and 407 (see Fig. 4) | <3 | * 18997 |
BD69 | 381 and 388 (see Fig. 4) | 27 | * 8900 |
429 and 437 (see Fig. 4) | <4 (less plasma) | ** 5569 | |
451 and 458 (see Fig. 4) | <3 | *** 20 |
Shown are the real time PCR viral RNA measurements of pooled plasma samples (two pooled samples per measurement; total plasma volume 6 mL; detection limit = 3 RNA copies/mL). The time points selected for the analyses are shown as days from the zero point adopted in figures 2, 4 and 8. In these time points, the macaques were under H-iART (unmarked), or off-treatment after therapy suspension (marked with “§”). As a control of the assay variability and to exclude PCR inhibition, spiked RNA measurements for each plasma sample are shown. The RNA copy numbers (in copies/mL) used for the spiked measurements were: * 8686; ** 8605; *** 34. The low copy number spike was chosen to double-check the absence of low-level viremia in macaque BD69 that was the only one showing detectable viral RNA during the first PCR run.